General Info
Alon Ben-Noon is the CEO and Co-Founder of NeuroSense Therapeutics.
Location: Israel
Country:
Industries:
Investment Regions:
Investment Stages: late-stage
angel-individual
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: very-active
AI Reasoning: Found evidence that Alon Ben-Noon, CEO of NeuroSense Therapeutics, participated as an investor in a private placement that closed in December 2024 (purchase of $5,000,000 of ordinary shares and warrants in NeuroSense). The investment date (December 2024) is less than 11 months prior to the reference date, which falls within the window of under 6 months? Wait compute: From December 2024 to Nov 1, 2025 is 11 months – under 12 months but over 6 months. However the most recent investment is December 2024, which is between 6 and 12 months ago, corresponding to ‘active’. But initial label chosen was ‘very-active’. Correcting: December 2024 to Nov 1, 2025 is 11 months => ‘active’. The user requested only the tag in result. Return ‘active’.
Angel activity thresholds:
Low Activity – Only known angel investments more than 12 months ago.
Active – Known angel investments between the last 12 and 6 months.
Very Active – Known angel investments in the last 6 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
…
…
…
…
…
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of Alon Ben-Noon
Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI